ARQT logo

Arcutis Biotherapeutics (ARQT) Operating profit

annual operating profit:

-$128.40M+$112.70M(+46.75%)
December 31, 2024

Summary

  • As of today (May 25, 2025), ARQT annual operating income is -$128.40 million, with the most recent change of +$112.70 million (+46.75%) on December 31, 2024.
  • During the last 3 years, ARQT annual operating profit has risen by +$78.13 million (+37.83%).
  • ARQT annual operating profit is now -3027.06% below its all-time high of -$4.11 million, reached on December 31, 2017.

Performance

ARQT Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

quarterly operating profit:

-$24.53M-$16.90M(-221.40%)
March 31, 2025

Summary

  • As of today (May 25, 2025), ARQT quarterly operating income is -$24.53 million, with the most recent change of -$16.90 million (-221.40%) on March 31, 2025.
  • Over the past year, ARQT quarterly operating profit has increased by +$7.09 million (+22.43%).
  • ARQT quarterly operating profit is now -312.04% below its all-time high of -$5.95 million, reached on December 31, 2018.

Performance

ARQT quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

TTM operating profit:

-$121.30M+$7.09M(+5.52%)
March 31, 2025

Summary

  • As of today (May 25, 2025), ARQT TTM operating income is -$121.30 million, with the most recent change of +$7.09 million (+5.52%) on March 31, 2025.
  • Over the past year, ARQT TTM operating profit has increased by +$75.15 million (+38.25%).
  • ARQT TTM operating profit is now -1937.70% below its all-time high of -$5.95 million, reached on December 31, 2018.

Performance

ARQT TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ARQT Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.8%+22.4%+38.3%
3 y3 years+37.8%+60.8%+48.0%
5 y5 years-197.7%+14.4%-87.1%

ARQT Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+57.4%-221.4%+76.6%at high+61.6%
5 y5-year-197.7%+57.4%-221.4%+76.6%-87.1%+61.6%
alltimeall time-3027.1%+57.4%-312.0%+76.6%-1937.7%+61.6%

ARQT Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$24.53M(+221.4%)
-$121.30M(-5.5%)
Dec 2024
-$128.40M(-46.7%)
-$7.63M(-80.5%)
-$128.40M(-29.4%)
Sep 2024
-
-$39.07M(-22.0%)
-$181.93M(+1.2%)
Jun 2024
-
-$50.08M(+58.4%)
-$179.77M(-8.5%)
Mar 2024
-
-$31.62M(-48.3%)
-$196.46M(-18.5%)
Dec 2023
-$241.10M(-20.1%)
-$61.17M(+65.8%)
-$241.10M(-2.9%)
Sep 2023
-
-$36.90M(-44.7%)
-$248.36M(-21.5%)
Jun 2023
-
-$66.76M(-12.5%)
-$316.20M(+0.3%)
Mar 2023
-
-$76.27M(+11.5%)
-$315.26M(+4.5%)
Dec 2022
-$301.63M(+46.0%)
-$68.42M(-34.7%)
-$301.63M(-0.9%)
Sep 2022
-
-$104.75M(+59.1%)
-$304.49M(+18.6%)
Jun 2022
-
-$65.83M(+5.1%)
-$256.82M(+10.2%)
Mar 2022
-
-$62.63M(-12.1%)
-$233.07M(+12.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$206.53M(+51.1%)
-$71.29M(+24.9%)
-$206.53M(+22.0%)
Sep 2021
-
-$57.08M(+35.6%)
-$169.31M(+12.5%)
Jun 2021
-
-$42.08M(+16.6%)
-$150.53M(+4.5%)
Mar 2021
-
-$36.09M(+5.9%)
-$144.08M(+5.4%)
Dec 2020
-$136.65M(+216.8%)
-$34.06M(-11.1%)
-$136.65M(+18.2%)
Sep 2020
-
-$38.30M(+7.5%)
-$115.58M(+25.7%)
Jun 2020
-
-$35.63M(+24.3%)
-$91.92M(+41.8%)
Mar 2020
-
-$28.65M(+120.5%)
-$64.83M(+50.3%)
Dec 2019
-$43.13M(+118.6%)
-$12.99M(-11.3%)
-$43.13M(+19.5%)
Sep 2019
-
-$14.65M(+71.6%)
-$36.09M(+68.3%)
Jun 2019
-
-$8.54M(+22.8%)
-$21.44M(+66.2%)
Mar 2019
-
-$6.95M(+16.8%)
-$12.90M(+116.8%)
Dec 2018
-$19.73M(+380.6%)
-$5.95M
-$5.95M
Dec 2017
-$4.11M
-
-

FAQ

  • What is Arcutis Biotherapeutics annual operating income?
  • What is the all time high annual operating profit for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual operating profit year-on-year change?
  • What is Arcutis Biotherapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics quarterly operating profit year-on-year change?
  • What is Arcutis Biotherapeutics TTM operating income?
  • What is the all time high TTM operating profit for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics TTM operating profit year-on-year change?

What is Arcutis Biotherapeutics annual operating income?

The current annual operating profit of ARQT is -$128.40M

What is the all time high annual operating profit for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual operating income is -$4.11M

What is Arcutis Biotherapeutics annual operating profit year-on-year change?

Over the past year, ARQT annual operating income has changed by +$112.70M (+46.75%)

What is Arcutis Biotherapeutics quarterly operating income?

The current quarterly operating profit of ARQT is -$24.53M

What is the all time high quarterly operating profit for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly operating income is -$5.95M

What is Arcutis Biotherapeutics quarterly operating profit year-on-year change?

Over the past year, ARQT quarterly operating income has changed by +$7.09M (+22.43%)

What is Arcutis Biotherapeutics TTM operating income?

The current TTM operating profit of ARQT is -$121.30M

What is the all time high TTM operating profit for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high TTM operating income is -$5.95M

What is Arcutis Biotherapeutics TTM operating profit year-on-year change?

Over the past year, ARQT TTM operating income has changed by +$75.15M (+38.25%)
On this page